Fidelis Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Sell |
5,355
-249
| -4% | -$96K | 0.19% | 96 |
|
|
2025
Q1 | $2.77M | Buy |
5,604
+84
| +2% | +$41.5K | 0.29% | 72 |
|
|
2024
Q4 | $2.6M | Buy |
5,520
+55
| +1% | +$25.9K | 0.26% | 73 |
|
|
2024
Q3 | $2.57M | Buy |
5,465
+285
| +6% | +$134K | 0.31% | 63 |
|
|
2024
Q2 | $2.41M | Buy |
5,180
+2,257
| +77% | +$1.05M | 0.34% | 55 |
|
|
2024
Q1 | $1.22M | Buy |
2,923
+1,138
| +64% | +$476K | 0.19% | 99 |
|
|
2023
Q4 | $726K | Buy |
1,785
+199
| +13% | +$81K | 0.16% | 129 |
|
|
2023
Q3 | $552K | Buy |
1,586
+190
| +14% | +$66.1K | 0.19% | 121 |
|
|
2023
Q2 | $491K | Buy |
1,396
+106
| +8% | +$37.3K | 0.18% | 133 |
|
|
2023
Q1 | $449K | Buy |
+1,290
| New | +$449K | 0.19% | 127 |
|